1 – 48 of 48
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis
(
- Contribution to journal › Article
-
Mark
Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
-
Mark
Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
2024) In Digestive Diseases and Sciences(
- Contribution to journal › Article
- 2023
-
Mark
Alkaline sphingomyelinase (NPP7) impacts the homeostasis of intestinal T lymphocyte populations
(
- Contribution to journal › Article
-
Mark
Emergency subtotal colectomy rates in relation to anti-TNF therapy in inflammatory bowel disease patients : comparison of retrospective cohorts
(
- Contribution to journal › Article
-
Mark
Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
(
- Contribution to journal › Article
-
Mark
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis : A Scandinavian Cohort Study
(
- Contribution to journal › Article
-
Mark
Impact of previous diverticulitis on 5-year survival and recurrence rates in patients with colorectal cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
(
- Contribution to journal › Article
-
Mark
Clinical effectiveness of golimumab in ulcerative colitis : a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
(
- Contribution to journal › Article
-
Mark
Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis : Results from a national register-based cohort study
(
- Contribution to journal › Article
-
Mark
Specialized pro-resolving mediators and the lymphatic system
(
- Contribution to journal › Scientific review
-
Mark
A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy : analysis of 8064 answers of international experts to an illustrated script questionnaire
(
- Contribution to journal › Article
- 2019
-
Mark
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis : Results from the SPARTAKUS cohort
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease registries for collection of patient iron parameters in Europe
(
- Contribution to journal › Scientific review
-
Mark
Fibre intake and the development of inflammatory bowel disease : A European prospective multi-centre cohort study (EPIC-IBD)
(
- Contribution to journal › Article
-
Mark
A Novel Topical PPAR 3 Agonist Induces PPAR 3 Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term effectiveness of vedolizumab in inflammatory bowel disease : a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
(
- Contribution to journal › Article
- 2013
-
Mark
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life
(
- Contribution to journal › Article
-
Mark
Collagenous colitis. Epidemiology, risk factors, clinical presentation and associated autoimmune disorders
(
- Thesis › Doctoral thesis (compilation)
-
Mark
High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: A longitudinal 2-year follow-up study
(
- Contribution to journal › Article
- 2012
-
Mark
Kolonkapselendoskopie: Leitlinie der Europäischen Gesellschaft für Gastrointestinale Endoskopie
(
- Contribution to journal › Article
-
Mark
Targeting T cell migration in inflammatory bowel disease.
(
- Contribution to journal › Article
- 2010
-
Mark
A maximum likelihood estimator of a Markov model for disease activity in Crohn's disease and ulcerative colitis for annually aggregated partial observations.
(
- Contribution to journal › Article
-
Mark
Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease
(
- Contribution to journal › Article
- 2009
-
Mark
Defining Clinical Criteria for Clinical Remission and Disease Activity in Collagenous Colitis
(
- Contribution to journal › Article
-
Mark
6-Thioguanine therapy in Crohn's disease-Observational data in Swedish patients
(
- Contribution to journal › Article
- 2007
-
Mark
High Proportions of Proinflammatory Bacteria on the Colonic Mucosa in a Young Patient with Ulcerative Colitis as Revealed by Cloning and Sequencing of 16S rRNA Genes.
(
- Contribution to journal › Article
-
Mark
Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: The first 100 patients treated in Scandinavia
(
- Contribution to journal › Article
-
Mark
Adolescents with inflammatory bowel disease feel ambivalent towards their parents' concern for them
(
- Contribution to journal › Article
-
Mark
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades : A population-based study from Copenhagen, Denmark
(
- Contribution to journal › Article
- 2006
-
Mark
Perinatal events and the risk of developing primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Phospholipid signals and intestinal carcinogenesis
(
- Contribution to journal › Article
-
Mark
Clinical studies of thiopurine metabolism in inflammatory bowel disease.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Alkaline sphingomyelinase: An old enzyme with novel implications.
(
- Contribution to journal › Scientific review
-
Mark
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity
(
- Contribution to journal › Article
-
Mark
Role of CCL25/CCR9 in immune homeostasis and disease
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Gastric and enteric Helicobacter species in animal models and in the human colon
2004)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
Roquinimex inhibits dextran sodium sulfate-induced murine colitis
(
- Contribution to journal › Article
-
Mark
On the regulation and effects of chronic inflammation in inflammatory bowel disease
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity
(
- Contribution to journal › Article
- 2000
-
Mark
Inflammatory bowel disease promotes venous thrombosis earlier in life
(
- Contribution to journal › Article
- 1995
-
Mark
Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role
(
- Contribution to journal › Article
- 1994
-
Mark
The Expression of Glutathione Transferase μ in Patients with Inflammatory Bowel Disease
(
- Contribution to journal › Article